Tag Archives: Keytruda

Breakthrough Melanoma Drug Gets FDA Approval

New drug gets accelerated approvalĀ  The U.S. Food and Drug Administration recently approved the drug pembrolizumab (Keytruda, Merck) for the use in treating advanced or unresectable melanoma in patients who have otherwise stopped responding to other drugs. The FDA granted … Continue reading

Posted in Dermatology, FDA, Melanoma, Skin Cancer | Tagged , , , , , , | Leave a comment